Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41,168,218
-
Total 13F shares
-
15,792,917
-
Share change
-
-132,190
-
Total reported value
-
$21,635,134
-
Put/Call ratio
-
1.7%
-
Price per share
-
$1.37
-
Number of holders
-
43
-
Value change
-
-$202,681
-
Number of buys
-
11
-
Number of sells
-
23
Institutional Holders of Apyx Medical Corp - Common Stock (APYX) as of Q1 2025
As of 31 Mar 2025,
Apyx Medical Corp - Common Stock (APYX) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,792,917 shares.
The largest 10 holders included
Archon Capital Management LLC, Nantahala Capital Management, LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, Silverberg Bernstein Capital Management LLC, HORIZON KINETICS ASSET MANAGEMENT LLC, COMMONWEALTH EQUITY SERVICES, LLC, Taylor Frigon Capital Management LLC, BlackRock, Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.